Skip to content

Optimizing the Effect of COPD Rehabilitation

Rehabilitation of COPD Patients: Can the Effect be Prolonged by Follow-up and Continued Rehabilitation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00419289
Enrollment
120
Registered
2007-01-08
Start date
2007-01-31
Completion date
2008-06-30
Last updated
2007-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

COPD, rehabilitation, quality of life

Brief summary

Patients with Chronic Obstructive Pulmonary Disease (COPD) may benefit from an 8-week pulmonary rehabilitation programme. However, the effect of the programme tends to attenuate with time. Patients who complete the programme are randomized to continued rehabilitation follow-up and control follow-up.

Detailed description

Patients with Chronic Obstructive Pulmonary Disease (COPD) may benefit from an 8-week pulmonary rehabilitation programme according to guidelines of the Danish Society of Pulmonary Medicine. However, the effect of programme tends to attenuate with time. Patients who complete the programme are randomized to continued rehabilitation follow-up and control follow-up.

Interventions

BEHAVIORALfollow-up rehabilitation of participants with COPD

Sponsors

Ministry of the Interior and Health, Denmark
CollaboratorOTHER_GOV
Glostrup University Hospital, Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* FEV1 \< 60% of expected

Exclusion criteria

* Other severe chronic conditions

Design outcomes

Primary

MeasureTime frame
Disease specific Quality of Life
Work Capacity

Secondary

MeasureTime frame
Number of days admitted to hospital

Countries

Denmark

Contacts

Primary ContactSusanne Vest, MD
susanne.vest@dadlnet.dk
Backup ContactAllan Linneberg, MD
alli@glostruphosp.kbhamt.dk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026